A clinical study on the utility of homoeopathic medicines in 50 millesimal potency in the management of cancer pain

Abstract

Cancer pain remains one of the most debilitating symptoms affecting patients' physical, emotional, and social wellbeing. This study evaluates the effectiveness of individualized homoeopathic medicines in 50 millesimal (LM) potencies for managing cancer-related pain. Twenty-five patients were assessed using the Numerical Pain Rating Scale over three months. Significant reductions in pain scores were observed, particularly during the second and third months, with 92% of patients showing marked improvement. LM potencies demonstrated rapid, gentle action with minimal aggravation. Findings suggest that individualized homoeopathic treatment may enhance pain relief and quality of life in cancer patients, warranting further controlled research.